ROBERT ECKERT - 17 May 2022 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Director
Signature
/s/ Robert A. Eckert
Issuer symbol
AMGN
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 21:52:47 UTC
Previous filing
10 May 2022
Next filing
20 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +855 +6.3% $0.000000 14,461 17 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2 These shares include 1,894 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.